Commentary|Podcasts|August 5, 2024
Empty Shelves, Urgent Solutions
Author(s)Miranda Schmalfuhs
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts, alternative solutions to ensure continued access to medications for all Americans, potential long term consequences if these pharmacy closures continue, and more
Advertisement
Michael Abrams, Managing Partner at Numerof & Associates discusses:
- Pharmacy deserts
- The main factors that are contributing to the closures of both large and independent pharmacies
- Alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities)
- Potential long term consequences if closures continue
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
3
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
4
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
5